| 7001 | C-reactive protein | Blood biochemistry | UKBB00000113 | 0.34 |
| 7002 | Lesion of plantar nerve | FING00000720 | 0.34 |
| 7003 | SOD3 levels | GCST90470706 | 0.34 |
| 7004 | MEGF10 levels | GCST90469882 | 0.34 |
| 7005 | BTN2A1/SIGLEC1 ratio | GCST90313548 | 0.34 |
| 7006 | GOPC levels | GCST90469377 | 0.34 |
| 7007 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77) | GCST90320896 | 0.34 |
| 7008 | Spinal stenosis of lumbar region (PheCode 720.1) | GCST90476234 | 0.34 |
| 7009 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T38 | ECGA000038 | 0.34 |
| 7010 | CIAPIN1/SNX9 ratio | GCST90314068 | 0.34 |
| 7011 | Anaemias | FING00000082 | 0.34 |
| 7012 | Alcohol use disorder, ICD-based | FING00000052 | 0.34 |
| 7013 | F11R/GP1BA ratio | GCST90314722 | 0.34 |
| 7014 | Right-hemisphere dorsal attention network to pallidum white-matter structural connectivity | GCST90302809 | 0.34 |
| 7015 | ERBB2/GUSB ratio | GCST90314687 | 0.34 |
| 7016 | PLA2G1B levels | GCST90470246 | 0.34 |
| 7017 | S100A14 levels | GCST90470515 | 0.34 |
| 7018 | LY6G6C levels | GCST90241830 | 0.34 |
| 7019 | Cancer of kidney and renal pelvis (PheCode 189.1) | GCST90475595 | 0.34 |
| 7020 | CCL5/CXCL3 ratio | GCST90313700 | 0.33 |
| 7021 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T148 | ECGU000148 | 0.33 |
| 7022 | Bioavailable testosterone levels | GCST90012102 | 0.33 |
| 7023 | CFC1 levels | GCST90468724 | 0.33 |
| 7024 | SEPTIN3 levels | GCST90470576 | 0.33 |
| 7025 | NCAN levels | GCST90618559 | 0.33 |
| 7026 | MSLN levels | GCST90469948 | 0.33 |
| 7027 | SIAE levels | GCST90470629 | 0.33 |
| 7028 | PLIN1/SNCG ratio | GCST90315677 | 0.33 |
| 7029 | Frailty (General Factor) | GCST90624046 | 0.33 |
| 7030 | IL1RL1 levels | GCST90469574 | 0.33 |
| 7031 | Mean corpuscular hemoglobin concentration | GCST90018745 | 0.33 |
| 7032 | Overall health rating | General health | UKBB00000621 | 0.33 |
| 7033 | TALDO1 levels | GCST90470802 | 0.33 |
| 7034 | STK4 levels | GCST90470767 | 0.33 |
| 7035 | CPA1/CTRC ratio | GCST90314204 | 0.33 |
| 7036 | Serum 25-Hydroxyvitamin D levels (conditioned on BMI) | GCST90000616 | 0.33 |
| 7037 | TMPRSS15 levels | GCST90470892 | 0.33 |
| 7038 | Hemoglobin | GCST90018737 | 0.33 |
| 7039 | Spondyloarthritis | FING00001323 | 0.33 |
| 7040 | Shortness of breath (PheCode 512.7) | GCST90476040 | 0.33 |
| 7041 | BGN levels | GCST90468441 | 0.33 |
| 7042 | DKK1/ZBTB16 ratio | GCST90314486 | 0.33 |
| 7043 | CLEC7A levels | GCST90468778 | 0.33 |
| 7044 | PEAR1/PECAM1 ratio | GCST90315641 | 0.33 |
| 7045 | Right-hemisphere visual network to caudate white-matter structural connectivity | GCST90302782 | 0.33 |
| 7046 | F-capsicum liking (derived food-liking factor) | GCST90094726 | 0.33 |
| 7047 | Placental weight (maternal genotype, adjusted for sex and gestational age) | GCST90275190 | 0.33 |
| 7048 | USP8 levels | GCST90471022 | 0.33 |
| 7049 | ATP5IF1/F2R ratio | GCST90313384 | 0.33 |
| 7050 | Number of puzzles correctly solved (baseline) | GCST90565840 | 0.32 |
| 7051 | Enteropathic arthropathies | FING00000508 | 0.32 |
| 7052 | Cereal type - Muesli | Diet | UKBB00000123 | 0.32 |
| 7053 | Phosphate levels (UKB data field 30810) | GCST90468094 | 0.32 |
| 7054 | DAG1/DKK1 ratio | GCST90314373 | 0.32 |
| 7055 | Nonalcoholic fatty liver disease | GCST90275041 | 0.32 |
| 7056 | Bursitis (PheCode 726.3) | GCST90476240 | 0.32 |
| 7057 | CD48/CRTAM ratio | GCST90313839 | 0.32 |
| 7058 | FHIT/PRTFDC1 ratio | GCST90314823 | 0.32 |
| 7059 | FABP4/FGF21 ratio | GCST90314758 | 0.32 |
| 7060 | aparc-Desikan lh volume parstriangularis | GCST90002787 | 0.32 |
| 7061 | Illnesses of father - Diabetes | Family history | UKBB00000341 | 0.32 |
| 7062 | Pulse pressure | GCST90472785 | 0.32 |
| 7063 | NPPC levels | GCST90470075 | 0.32 |
| 7064 | F-fatty food liking (derived food-liking factor) | GCST90094761 | 0.32 |
| 7065 | RRAS levels | GCST90470499 | 0.32 |
| 7066 | ELN levels | GCST90469103 | 0.32 |
| 7067 | Testosterone levels | GCST90483487 | 0.32 |
| 7068 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 51) | GCST90320614 | 0.32 |
| 7069 | Valine levels (UKB data field 23467) | GCST90269564 | 0.32 |
| 7070 | Benign neoplasm of colon (PheCode 208) | GCST90475617 | 0.32 |
| 7071 | Urine GlcNAc sulfate conjugate of C21H34O2 steroid** levels in chronic kidney disease | GCST90265175 | 0.32 |
| 7072 | Nonischemic cardiomyopathy | FING00000883 | 0.32 |
| 7073 | TGFB1 levels | GCST90274818 | 0.32 |
| 7074 | DTI TBSS FA Splenium of corpus callosum | GCST90384384 | 0.32 |
| 7075 | SCARA3 levels | GCST90427856 | 0.32 |
| 7076 | DYNLL1 levels | GCST90240984 | 0.32 |
| 7077 | Right-hemisphere somatomotor network to thalamus white-matter structural connectivity | GCST90302794 | 0.32 |
| 7078 | OMD/SOST ratio | GCST90315585 | 0.32 |
| 7079 | CD48 levels | GCST90425676 | 0.32 |
| 7080 | BA-exvivo rh volume V2 | GCST90002859 | 0.31 |
| 7081 | PLA2G4A/SDC4 ratio | GCST90315668 | 0.31 |
| 7082 | CD302 levels | GCST90468624 | 0.31 |
| 7083 | Bone density (confirmatory factor analysis Factor 19) | GCST90309353 | 0.31 |
| 7084 | Medication use (agents acting on the renin-angiotensin system) | GCST90018768 | 0.31 |
| 7085 | SAMD9L levels | GCST90470524 | 0.31 |
| 7086 | CD7 levels | GCST90468649 | 0.31 |
| 7087 | PDZK1 levels | GCST90470203 | 0.31 |
| 7088 | CGA levels | GCST90468732 | 0.31 |
| 7089 | SPRY2/YTHDF3 ratio | GCST90315881 | 0.31 |
| 7090 | SPINK5/SPINT1 ratio | GCST90315877 | 0.31 |
| 7091 | DTI TBSS MD External capsule R | GCST90384604 | 0.31 |
| 7092 | IDP dMRI ProbtrackX MO atr r | GCST90004003 | 0.31 |
| 7093 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T424 | ECGU000424 | 0.31 |
| 7094 | IDP dMRI TBSS L2 Pontine crossing tract | GCST90004124 | 0.31 |
| 7095 | IDP dMRI TBSS L3 Superior longitudinal fasciculus L | GCST90004212 | 0.31 |
| 7096 | Bleeding | FING00000219 | 0.31 |
| 7097 | MATN2 levels | GCST90469864 | 0.31 |
| 7098 | CCL26 levels | GCST90468578 | 0.31 |
| 7099 | T1 FreeSurfer a2009s lh S postcentral volume | GCST90384882 | 0.31 |
| 7100 | SNAP23 levels | GCST90470690 | 0.31 |
| 7101 | IDP dMRI TBSS L3 Cingulum hippocampus R | GCST90004207 | 0.31 |
| 7102 | LCN2/RETN ratio | GCST90315308 | 0.31 |
| 7103 | Diabetes mellitus (PheCode 250) | GCST90475658 | 0.31 |
| 7104 | PFDN5 levels | GCST90242340 | 0.31 |
| 7105 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T221 | ECGU000221 | 0.31 |
| 7106 | Placental weight (fetal genotype, adjusted for sex) | GCST90275197 | 0.30 |
| 7107 | Glucose (fasting status unknown, mean, inv-norm transformed) | GCST90475332 | 0.30 |
| 7108 | SNX9 levels | GCST90470703 | 0.30 |
| 7109 | Linoleic acid levels | GCST90502012 | 0.30 |
| 7110 | LPP levels | GCST90469790 | 0.30 |
| 7111 | Vascular/heart problems diagnosed by doctor - Angina | Medical conditions | UKBB00000896 | 0.30 |
| 7112 | TARBP2 levels | GCST90470805 | 0.30 |
| 7113 | CORO1A levels | GCST90468832 | 0.30 |
| 7114 | Polycystic ovarian syndrome, consortium definition | FING00001184 | 0.30 |
| 7115 | DTI TBSS L1 Posterior thalamic radiation L | GCST90384457 | 0.30 |
| 7116 | Takes medication for enlarged prostate (Benign prostatic hyperplasia)? | GCST90475262 | 0.30 |
| 7117 | SLAMF1 levels | GCST90470649 | 0.30 |
| 7118 | SEMA7A levels | GCST90470575 | 0.30 |
| 7119 | Primary/intrinsic cardiomyopathies (PheCode 425.1) | GCST90475951 | 0.30 |
| 7120 | aparc-DKTatlas lh thickness cuneus | GCST90003543 | 0.30 |
| 7121 | Free cholesterol levels in large LDL | GCST003665 | 0.30 |
| 7122 | Omega-6 fatty acid levels | GCST90502103 | 0.30 |
| 7123 | Alcohol usually taken with meals (UKB data field 1618) | GCST90133004 | 0.30 |
| 7124 | F-sharp flavour liking (derived food-liking factor) | GCST90094837 | 0.30 |
| 7125 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T138 | ECGU000138 | 0.30 |
| 7126 | Lysoalkylphosphatidylcholine (O-24:1) levels | GCST90024813 | 0.30 |
| 7127 | Soft tissue disorders | FING00001316 | 0.30 |
| 7128 | TFPI2 levels | GCST90470838 | 0.30 |
| 7129 | MAN2B2 levels | GCST90469844 | 0.30 |
| 7130 | Cataract | sense organs | UKBB00000120 | 0.30 |
| 7131 | FLT3/FLT3LG ratio | GCST90314859 | 0.30 |
| 7132 | SERPINH1 levels | GCST90470601 | 0.30 |
| 7133 | NID1/NID2 ratio | GCST90315541 | 0.30 |
| 7134 | X-17357 levels | GCST90200550 | 0.29 |
| 7135 | Non-cancer illness code, self-reported - angina | Medical conditions | UKBB00000505 | 0.29 |
| 7136 | LY96 levels | GCST90469823 | 0.29 |
| 7137 | IL1R1/IL1RN ratio | GCST90315158 | 0.29 |
| 7138 | Volume of right lateral nucleus | GCST90475034 | 0.29 |
| 7139 | Bone marrow fat fraction of lumbar vertebra 5 | GCST90652390 | 0.29 |
| 7140 | CTSE levels | GCST90468911 | 0.29 |
| 7141 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T133 | ECGU000133 | 0.29 |
| 7142 | Total concentration of branched-chain amino acids (leucine + isoleucine + valine) (UKB data field 23464) | GCST90269561 | 0.29 |
| 7143 | Myocardial fractal dimension (slice 7) | GCST90000293 | 0.29 |
| 7144 | Left ventricular ejection fraction | GCST90268125 | 0.29 |
| 7145 | PITHD1 levels | GCST90470239 | 0.29 |
| 7146 | CLEC1B levels | GCST90468768 | 0.29 |
| 7147 | FKBP14 levels | GCST90469241 | 0.29 |
| 7148 | BANK1/FOXO1 ratio | GCST90313456 | 0.29 |
| 7149 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T61 | ECGA000061 | 0.29 |
| 7150 | Snoring | GCST009763 | 0.29 |
| 7151 | Fluid intelligence score decline (difference score) | GCST90565862 | 0.29 |
| 7152 | Visceral adipose tissue normalized | GCST90267358 | 0.29 |
| 7153 | CD83/TNFRSF4 ratio | GCST90313907 | 0.29 |
| 7154 | Provencibacterium abundance in stool | GCST90032528 | 0.29 |
| 7155 | Abdominal aortic calcification levels | GCST90134614 | 0.29 |
| 7156 | KIT levels | GCST90469692 | 0.29 |
| 7157 | Abdominal subcutaneous adipose tissue normalized | GCST90267348 | 0.29 |
| 7158 | NME3 levels | GCST90470055 | 0.29 |
| 7159 | DTI TBSS L3 Posterior limb of internal capsule R | GCST90384542 | 0.29 |
| 7160 | Cardiorespiratory fitness (vo2 max) | GCST90093317 | 0.29 |
| 7161 | GUCA2A levels | GCST90469418 | 0.29 |
| 7162 | LPCAT2/SERPINB8 ratio | GCST90315328 | 0.29 |
| 7163 | CPB1 levels | GCST90240597 | 0.29 |
| 7164 | DNAJB2 levels | GCST90469013 | 0.29 |
| 7165 | SSNA1 levels | GCST90470750 | 0.29 |
| 7166 | EPCAM/GPA33 ratio | GCST90314674 | 0.29 |
| 7167 | CD22/SEMA7A ratio | GCST90313759 | 0.29 |
| 7168 | ABL1/PDLIM7 ratio | GCST90313150 | 0.28 |
| 7169 | Intelligence | GCST004364 | 0.28 |
| 7170 | IDP T1 FAST ROIs L front operc cortex | GCST90002531 | 0.28 |
| 7171 | LAT/VASH1 ratio | GCST90315289 | 0.28 |
| 7172 | DKK4 levels | GCST90468999 | 0.28 |
| 7173 | Pain type(s) experienced in last month - Headache | Pain | UKBB00000627 | 0.28 |
| 7174 | Qualifications - None of the above | Education | UKBB00000729 | 0.28 |
| 7175 | Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers) | FING00000316 | 0.28 |
| 7176 | Plasma pregnenetriol disulfate* levels in chronic kidney disease | GCST90265864 | 0.28 |
| 7177 | Lymphoid leukemia, chronic (PheCode 204.12) | GCST90475613 | 0.28 |
| 7178 | F2R levels | GCST90469168 | 0.28 |
| 7179 | Internal derangement of knee | injuries & poisonings | UKBB00000368 | 0.28 |
| 7180 | Migraine (PheCode 340) | GCST90475837 | 0.28 |
| 7181 | Nasal polyps | GCST90468143 | 0.28 |
| 7182 | COL24A1 levels | GCST90468814 | 0.28 |
| 7183 | Superficial cellulitis and abscess (PheCode 681) | GCST90476165 | 0.28 |
| 7184 | aparc-Desikan lh area parstriangularis | GCST90003092 | 0.28 |
| 7185 | Broad bean liking | GCST90094711 | 0.28 |
| 7186 | VSNL1 levels | GCST90471054 | 0.28 |
| 7187 | T1 FreeSurfer DK lh lateraloccipital area | GCST90385598 | 0.28 |
| 7188 | Anorexia (incl.atypical) | FING00000093 | 0.28 |
| 7189 | Type 2 diabetes (PheCode 250.2) | GCST90475667 | 0.28 |
| 7190 | aparc-DKTatlas rh thickness pericalcarine | GCST90003590 | 0.28 |
| 7191 | LY96/ST6GAL1 ratio | GCST90315348 | 0.28 |
| 7192 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T230 | ECGA000230 | 0.28 |
| 7193 | ADGRE5/SEMA7A ratio | GCST90313183 | 0.28 |
| 7194 | CXCL11 levels | GCST90274781 | 0.27 |
| 7195 | Anxiety, nerves or generalized anxiety disorder | Mental distress | UKBB00000039 | 0.27 |
| 7196 | FXN/METAP1D ratio | GCST90314897 | 0.27 |
| 7197 | Total cholesterol levels in LDL | GCST90132686 | 0.27 |
| 7198 | Sarcoidosis | FING00001275 | 0.27 |
| 7199 | Vitamin D | Blood biochemistry | UKBB00000902 | 0.27 |
| 7200 | aparc-a2009s rh area G-pariet-inf-Supramar | GCST90003396 | 0.27 |
| 7201 | BA-exvivo lh thickness MT | GCST90003524 | 0.27 |
| 7202 | Biological Grandparent (paternal): Diabetes / Sugar | GCST90475549 | 0.27 |
| 7203 | PALM3 levels | GCST90470153 | 0.27 |
| 7204 | Acute myocardial infarction | Ischaemic heart diseases | UKBB00000011 | 0.27 |
| 7205 | Sacroiliitis, not elsewhere classified | FING00001273 | 0.27 |
| 7206 | KLF4 levels | GCST90469694 | 0.27 |
| 7207 | BA-exvivo lh area BA45 | GCST90003215 | 0.27 |
| 7208 | total creatine kinase (mean, inv-norm transformed) | GCST90476413 | 0.27 |
| 7209 | GERD | digestive | UKBB00000283 | 0.27 |
| 7210 | TNFRSF1A/TNFRSF1B ratio | GCST90315937 | 0.27 |
| 7211 | aparc-Desikan rh volume cuneus | GCST90002805 | 0.27 |
| 7212 | Chained arithmetic | Fluid intelligence / reasoning | UKBB00000126 | 0.27 |
| 7213 | DTI TBSS L3 Posterior corona radiata R | GCST90384550 | 0.27 |
| 7214 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T425 | ECGU000425 | 0.27 |
| 7215 | AFP levels | GCST90278615 | 0.27 |
| 7216 | Left hippocampal volume (body) | GCST90267948 | 0.26 |
| 7217 | IDP dMRI ProbtrackX ICVF ptr l | GCST90004394 | 0.26 |
| 7218 | PARK7/TNFRSF9 ratio | GCST90315599 | 0.26 |
| 7219 | Leucine levels | GCST90243405 | 0.26 |
| 7220 | Mean reticulocyte volume | GCST90002396 | 0.26 |
| 7221 | TNIP1 levels | GCST90470925 | 0.26 |
| 7222 | Sleep disorders (combined) | FING00001311 | 0.26 |
| 7223 | GRPEL1 levels | GCST90469405 | 0.26 |
| 7224 | Recent feelings of tiredness or low energy | Depression | UKBB00000740 | 0.26 |
| 7225 | Urinary albumin-to-creatinine ratio | GCST009640 | 0.26 |
| 7226 | Hereditary hemolytic anemias (PheCode 282) | GCST90475779 | 0.26 |
| 7227 | Linoleic acid levels | GCST90502311 | 0.26 |
| 7228 | Later onset COPD | FING00000714 | 0.26 |
| 7229 | DPP6/NELL2 ratio | GCST90314541 | 0.26 |
| 7230 | Pulse pressure | GCST90301703 | 0.26 |
| 7231 | Pregnenolone sulfate levels | GCST90199873 | 0.26 |
| 7232 | HSPB6/SNCG ratio | GCST90315090 | 0.26 |
| 7233 | UCMA levels | GCST90243285 | 0.26 |
| 7234 | FGF23 levels | GCST90469223 | 0.26 |
| 7235 | Pulse pressure | GCST90301701 | 0.26 |
| 7236 | ASRGL1 levels | GCST90468379 | 0.25 |
| 7237 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T33 | ECGA000033 | 0.25 |
| 7238 | Other soft tissue disorders, not elsewhere classified | FING00001099 | 0.25 |
| 7239 | ITIH3 levels | GCST90469650 | 0.25 |
| 7240 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502068 | 0.25 |
| 7241 | Social trust (aggregated) | GCST90319315 | 0.25 |
| 7242 | Age at first sexual intercourse | GCST90000046 | 0.25 |
| 7243 | RBP2 levels | GCST90470438 | 0.25 |
| 7244 | SERPINF1 levels | GCST90470598 | 0.25 |
| 7245 | T1 FreeSurfer a2009s lh S central thickness | GCST90384786 | 0.25 |
| 7246 | KLK6/PTPRN2 ratio | GCST90315256 | 0.25 |
| 7247 | Glycated haemoglobin (HbA1c) | Blood biochemistry | UKBB00000289 | 0.25 |
| 7248 | Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) | GCST90475091 | 0.25 |
| 7249 | COL18A1 levels | GCST90468812 | 0.25 |
| 7250 | Continuous positive airway pressure | FING00000349 | 0.25 |
| 7251 | ICD10 N92: Excessive, frequent and irregular menstruation | GCST90454221 | 0.25 |
| 7252 | CD63 levels | GCST90468642 | 0.25 |
| 7253 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3) | GCST90320566 | 0.25 |
| 7254 | IDP dMRI TBSS L2 Cingulum cingulate gyrus L | GCST90004158 | 0.25 |
| 7255 | Mean volume of bilateral amygdala | GCST90474901 | 0.25 |
| 7256 | Type 1 diabetes | GCST90018705 | 0.25 |
| 7257 | SETMAR levels | GCST90470605 | 0.25 |
| 7258 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T303 | ECGA000303 | 0.25 |
| 7259 | HBEGF/YES1 ratio | GCST90315039 | 0.25 |
| 7260 | X-11444 metabolite level | GCST90616545 | 0.25 |
| 7261 | PMVK/PRTFDC1 ratio | GCST90315695 | 0.25 |
| 7262 | GRN levels | GCST90469404 | 0.25 |
| 7263 | NCAM1 levels | GCST90470003 | 0.25 |
| 7264 | SNAP29/VEGFC ratio | GCST90315862 | 0.25 |
| 7265 | LMNB2 levels | GCST90469782 | 0.25 |
| 7266 | LGMN levels | GCST90469766 | 0.25 |
| 7267 | Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418) | GCST90132986 | 0.24 |
| 7268 | PTPRR levels | GCST90470386 | 0.24 |
| 7269 | CD4 levels | GCST90468636 | 0.24 |
| 7270 | IDP SWI T2star right caudate | GCST90003866 | 0.24 |
| 7271 | CD300C/LRRC25 ratio | GCST90313790 | 0.24 |
| 7272 | LGALS3BP levels | GCST90469760 | 0.24 |
| 7273 | PAXX levels | GCST90470161 | 0.24 |
| 7274 | KIAA2013 levels | GCST90469679 | 0.24 |
| 7275 | White blood cell count | GCST90025985 | 0.24 |
| 7276 | Myocardial infarction (PheCode 411.2) | GCST90475932 | 0.24 |
| 7277 | CRTAM/KLRD1 ratio | GCST90314277 | 0.24 |
| 7278 | F3/GFRA1 ratio | GCST90314741 | 0.24 |
| 7279 | Neonatal jaundice (paternal effect) | GCST90435147 | 0.24 |
| 7280 | How many years have you or did you smoke cigarettes? (inv-normal transformed) | GCST90476390 | 0.24 |
| 7281 | CA14 levels | GCST90468509 | 0.24 |
| 7282 | Breast cancer | GCST004988 | 0.24 |
| 7283 | Cake icing liking | GCST90094723 | 0.24 |
| 7284 | Hypertensive chronic kidney disease (PheCode 401.22) | GCST90475927 | 0.24 |
| 7285 | Drinks usually with meals in current drinkers (yes and it varies vs no) (UKB data field 1618) | GCST90132925 | 0.24 |
| 7286 | IDP dMRI ProbtrackX L3 ifo r | GCST90004313 | 0.24 |
| 7287 | IDP dMRI ProbtrackX ISOVF fmi | GCST90004536 | 0.24 |
| 7288 | B4GALT1 levels | GCST90468412 | 0.24 |
| 7289 | IDP dMRI ProbtrackX L3 slf r | GCST90004322 | 0.24 |
| 7290 | Benign neoplasm of skin (PheCode 216) | GCST90475620 | 0.24 |
| 7291 | CD84/DKK1 ratio | GCST90313911 | 0.24 |
| 7292 | FSTL3/LTBR ratio | GCST90314883 | 0.24 |
| 7293 | ADH4 levels | GCST90468244 | 0.24 |
| 7294 | EIF4B/IPCEF1 ratio | GCST90314622 | 0.24 |
| 7295 | PRG2 levels | GCST90470322 | 0.24 |
| 7296 | VEGFC levels | GCST90471036 | 0.24 |
| 7297 | GPRC5C levels | GCST90469398 | 0.24 |
| 7298 | RRM2 levels | GCST90470501 | 0.23 |
| 7299 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T292 | ECGU000292 | 0.23 |
| 7300 | Ulcerative colitis (PheCode 555.2) | GCST90044155 | 0.23 |
| 7301 | Ganglion cell inner plexiform layer (GCIPL) thickness | GCST90014267 | 0.23 |
| 7302 | BGLAP levels | GCST90468440 | 0.23 |
| 7303 | PSMG3 levels | GCST90470362 | 0.23 |
| 7304 | REG1B levels | GCST90470448 | 0.23 |
| 7305 | Salad dressing liking | GCST90094822 | 0.23 |
| 7306 | IDP dMRI ProbtrackX L1 ilf l | GCST90004260 | 0.23 |
| 7307 | Leg fat percentage left (UKB data field 23115) | GCST90468174 | 0.23 |
| 7308 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44) | GCST90320863 | 0.23 |
| 7309 | Serum 25-Hydroxyvitamin D levels | GCST90000618 | 0.23 |
| 7310 | CTSD levels | GCST90468910 | 0.23 |
| 7311 | Benign mammary dysplasia | FING00000151 | 0.23 |
| 7312 | CA6 levels | GCST90468515 | 0.23 |
| 7313 | ANPEP/NT5E ratio | GCST90313274 | 0.23 |
| 7314 | C36:4 Phosphatidylethanolamine levels in chronic kidney disease | GCST90257357 | 0.23 |
| 7315 | LAMA4/NID1 ratio | GCST90315272 | 0.23 |
| 7316 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72) | GCST90320891 | 0.23 |
| 7317 | IDP dMRI TBSS FA Posterior thalamic radiation R | GCST90003905 | 0.23 |
| 7318 | Other disorders of testis (PheCode 603) | GCST90476156 | 0.23 |
| 7319 | Hip circumference | GCST90278633 | 0.23 |
| 7320 | red blood cell count (RBC, maximum, inv-norm transformed) | GCST90476345 | 0.23 |
| 7321 | FCER2/FCRL1 ratio | GCST90314789 | 0.23 |
| 7322 | rfMRI connectivity (ICA100 edge 995) | GCST90005848 | 0.23 |
| 7323 | IL2RA levels | GCST90469585 | 0.23 |
| 7324 | IFNGR2 levels | GCST90469514 | 0.23 |
| 7325 | Number of non-cancer illnesses (standard GWA) | GCST90267290 | 0.23 |
| 7326 | Tyrosine levels | GCST90500143 | 0.23 |
| 7327 | Age at first birth | GCST90000050 | 0.23 |
| 7328 | KLK6 levels | GCST90012008 | 0.22 |
| 7329 | Cerebral ischemia (PheCode 433.3) | GCST90475988 | 0.22 |
| 7330 | IDP dMRI TBSS FA Sagittal stratum L | GCST90003908 | 0.22 |
| 7331 | Chronic sinusitis | FING00000298 | 0.22 |
| 7332 | CDHR2 levels | GCST90468679 | 0.22 |
| 7333 | hematocrit (mean, inv-norm transformed) | GCST90475341 | 0.22 |
| 7334 | Tonsillectomy and adenotomy | FING00001367 | 0.22 |
| 7335 | ARSA levels | GCST90468368 | 0.22 |
| 7336 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T62 | ECGA000062 | 0.22 |
| 7337 | CXADR/GGT1 ratio | GCST90314328 | 0.22 |
| 7338 | Gamma glutamyltransferase levels (UKB data field 30730) | GCST90468070 | 0.22 |
| 7339 | IDP dMRI TBSS L2 Superior corona radiata L | GCST90004148 | 0.22 |
| 7340 | EREG/MPI ratio | GCST90314705 | 0.22 |
| 7341 | Migraine headaches | GCST90475546 | 0.22 |
| 7342 | TNFSF11 levels | GCST90274844 | 0.22 |
| 7343 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60) | GCST90320879 | 0.22 |
| 7344 | Treatment/medication code - aspirin | Medications | UKBB00000841 | 0.22 |
| 7345 | Beans liking | GCST90094699 | 0.22 |
| 7346 | Left-hemisphere control network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302746 | 0.22 |
| 7347 | Recent inability to stop or control worrying | Anxiety | UKBB00000742 | 0.22 |
| 7348 | Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) | GCST90475097 | 0.22 |
| 7349 | IDP dMRI ProbtrackX MD str r | GCST90004243 | 0.22 |
| 7350 | Pre-eclampsia | FING00001200 | 0.22 |
| 7351 | ADAM8 levels | GCST90468220 | 0.22 |
| 7352 | Diacylglycerol (14:0_18:2) levels | GCST90024705 | 0.22 |
| 7353 | IPCEF1 levels | GCST90469624 | 0.22 |
| 7354 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T153 | ECGU000153 | 0.22 |
| 7355 | Acute upper respiratory infections of multiple and unspecified sites | FING00000035 | 0.22 |
| 7356 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T368 | ECGU000368 | 0.22 |
| 7357 | IDP dMRI ProbtrackX L2 unc l | GCST90004298 | 0.22 |
| 7358 | Body mass index (MTAG) | GCST90179150 | 0.22 |
| 7359 | Childhood maltreatment | GCST90551844 | 0.22 |
| 7360 | GGACT levels | GCST90469333 | 0.22 |
| 7361 | IDP T1 FAST ROIs L temporal pole | GCST90002465 | 0.22 |
| 7362 | IDP T1 FAST ROIs L cerebellum crus II | GCST90002572 | 0.21 |
| 7363 | HEXIM1 levels | GCST90469447 | 0.21 |
| 7364 | EBI3_IL27/VCAM1 ratio | GCST90314572 | 0.21 |
| 7365 | rfMRI amplitudes (ICA25 node 12) | GCST90004579 | 0.21 |
| 7366 | EIF1AX levels | GCST90241120 | 0.21 |
| 7367 | GTPBP2 levels | GCST90469417 | 0.21 |
| 7368 | CLPS/PLA2G1B ratio | GCST90314140 | 0.21 |
| 7369 | FYB1/MESD ratio | GCST90314911 | 0.21 |
| 7370 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T367 | ECGU000367 | 0.21 |
| 7371 | Age high blood pressure diagnosed | Medical conditions | UKBB00000016 | 0.21 |
| 7372 | RSPO1 levels | GCST90470503 | 0.21 |
| 7373 | CTSF levels | GCST90468912 | 0.21 |
| 7374 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T311 | ECGU000311 | 0.21 |
| 7375 | CNTNAP4 levels | GCST90468809 | 0.21 |
| 7376 | ATP5IF1 levels | GCST90468392 | 0.21 |
| 7377 | CA4 levels | GCST90468513 | 0.21 |
| 7378 | DAB2/GRAP2 ratio | GCST90314364 | 0.21 |
| 7379 | Phospholipid levels in large LDL | GCST90132648 | 0.21 |
| 7380 | Aspartate aminotransferase | Blood biochemistry | UKBB00000052 | 0.21 |
| 7381 | hematocrit (minimum, inv-norm transformed) | GCST90475344 | 0.21 |
| 7382 | Colitis, primary sclerosing, strict definition | FING00000313 | 0.21 |
| 7383 | wg rh intensity-contrast isthmuscingulate | GCST90003836 | 0.21 |
| 7384 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T370 | ECGU000370 | 0.21 |
| 7385 | NRP2 levels | GCST90470086 | 0.21 |
| 7386 | Heart failure | GCST90399712 | 0.21 |
| 7387 | IDP dMRI ProbtrackX L2 ar r | GCST90004274 | 0.21 |
| 7388 | CTF1/ITGB1BP2 ratio | GCST90314305 | 0.21 |
| 7389 | Age at first sexual intercourse | GCST90000045 | 0.21 |
| 7390 | ELOA levels | GCST90469104 | 0.21 |
| 7391 | Glaucoma (multi-trait analysis) | GCST009722 | 0.20 |
| 7392 | DOK2/PPP1R2 ratio | GCST90314537 | 0.20 |
| 7393 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122) | GCST90320941 | 0.20 |
| 7394 | Hemoglobin A1c (HbA1c, mean, inv-norm transformed) | GCST90475094 | 0.20 |
| 7395 | SPARC/ZBTB16 ratio | GCST90315875 | 0.20 |
| 7396 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 107) | GCST90320670 | 0.20 |
| 7397 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T59 | ECGA000059 | 0.20 |
| 7398 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T384 | ECGU000384 | 0.20 |
| 7399 | Other and unspecified rosacea | FING00000951 | 0.20 |
| 7400 | Hip circumference adjusted for BMI | GCST012227 | 0.20 |
| 7401 | Clonal haematopoiesis of indeterminate potential (TET2 mutation) | GCST90165281 | 0.20 |
| 7402 | HIP1R levels | GCST90469453 | 0.20 |
| 7403 | Eosinophil percentage of white cells variance | GCST90565690 | 0.20 |
| 7404 | Platelet count during second trimester of pregnancy | GCST90302225 | 0.20 |
| 7405 | Medication use (antithrombotic agents) | GCST90018762 | 0.20 |
| 7406 | Pain in limb | FING00001138 | 0.20 |
| 7407 | L1CAM/SEZ6L ratio | GCST90315266 | 0.20 |
| 7408 | FCRL1/TNFRSF13C ratio | GCST90314796 | 0.20 |
| 7409 | Hair colour (natural, before greying) - Blonde | Sun exposure | UKBB00000296 | 0.20 |
| 7410 | General happiness with own health | Happiness and subjective well-being | UKBB00000281 | 0.20 |
| 7411 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T157 | ECGU000157 | 0.20 |
| 7412 | CACYBP levels | GCST90468524 | 0.20 |
| 7413 | aparc-a2009s rh thickness G-oc-temp-med-Lingual | GCST90003698 | 0.20 |
| 7414 | Iliac isthmus breadth | GCST90448907 | 0.20 |
| 7415 | IDP dMRI ProbtrackX L2 slf r | GCST90004295 | 0.20 |
| 7416 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 48) | GCST90320611 | 0.20 |
| 7417 | CD27/TGFBR2 ratio | GCST90313776 | 0.20 |
| 7418 | DTI TBSS MD Anterior limb of internal capsule R | GCST90384588 | 0.20 |
| 7419 | O-sulfo-l-tyrosine levels | GCST90243623 | 0.20 |
| 7420 | SNAP23/TBL1X ratio | GCST90315856 | 0.20 |
| 7421 | PAFAH1B3 levels | GCST90470145 | 0.19 |
| 7422 | Rosacea (PheCode 695.3) | GCST90476178 | 0.19 |
| 7423 | MPIG6B/PLXNA4 ratio | GCST90315483 | 0.19 |
| 7424 | Other disorders of ear | FING00001023 | 0.19 |
| 7425 | ADGRE5 levels | GCST90425484 | 0.19 |
| 7426 | Platelet count during first trimester of pregnancy | GCST90302224 | 0.19 |
| 7427 | Diabetes (weighted GWA) | GCST90267279 | 0.19 |
| 7428 | ROR1/TNFRSF21 ratio | GCST90315787 | 0.19 |
| 7429 | DLL1/EFEMP1 ratio | GCST90314494 | 0.19 |
| 7430 | ERBB2/PTPRF ratio | GCST90314688 | 0.19 |
| 7431 | Current tobacco smoking | Smoking | UKBB00000161 | 0.19 |
| 7432 | VEGFC/ZBTB16 ratio | GCST90315946 | 0.19 |
| 7433 | aparc-DKTatlas lh area parstriangularis | GCST90003252 | 0.19 |
| 7434 | Mean sphered cell volume (UKB data field 30270) | GCST90468089 | 0.19 |
| 7435 | Prescriptions - latanoprost | prostaglandin analog | UKBB00000686 | 0.19 |
| 7436 | PPP3R1 levels | GCST90470307 | 0.19 |
| 7437 | rfMRI connectivity (ICA100 edge 387) | GCST90005240 | 0.19 |
| 7438 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34 | ECGA000034 | 0.19 |
| 7439 | Psoriatic arthritis vs Cutaneous psoriasis | GCST90243957 | 0.19 |
| 7440 | DIABLO/MITD1 ratio | GCST90314467 | 0.19 |
| 7441 | GP6/SELP ratio | GCST90314970 | 0.19 |
| 7442 | Frailty (Factor 5 - Poorer Cognition) | GCST90624051 | 0.19 |
| 7443 | NTF4 levels | GCST90470095 | 0.19 |
| 7444 | CDH3 levels | GCST90468674 | 0.19 |
| 7445 | FABP2/RBP2 ratio | GCST90314757 | 0.19 |
| 7446 | BPIFA2 levels | GCST90468461 | 0.19 |
| 7447 | Principal component-derived dietary pattern 7 | GCST90133012 | 0.19 |
| 7448 | BST2/CXADR ratio | GCST90313538 | 0.19 |
| 7449 | STC1 levels | GCST90470761 | 0.18 |
| 7450 | aparc-a2009s rh volume S-intrapariet+P-trans | GCST90003054 | 0.18 |
| 7451 | Degree of unsaturation | GCST90502224 | 0.18 |
| 7452 | Osteoarthrosis NOS (PheCode 740.9) | GCST90476256 | 0.18 |
| 7453 | NBL1/TGFBR2 ratio | GCST90315515 | 0.18 |
| 7454 | IDP dMRI ProbtrackX L1 slf l | GCST90004267 | 0.18 |
| 7455 | CD163/SIGLEC1 ratio | GCST90313739 | 0.18 |
| 7456 | SPINT2/TNFSF13 ratio | GCST90315879 | 0.18 |
| 7457 | PDCD1/TNFRSF4 ratio | GCST90315609 | 0.18 |
| 7458 | Interpolated Year when operation took place | Operations | UKBB00000372 | 0.18 |
| 7459 | Mean volume of bilateral amygdala | GCST90474997 | 0.18 |
| 7460 | EDAR/LAT2 ratio | GCST90314582 | 0.18 |
| 7461 | IGF1 levels | GCST90025989 | 0.18 |
| 7462 | aparc-a2009s rh volume G-cuneus | GCST90003009 | 0.18 |
| 7463 | MAP4K5/STAMBP ratio | GCST90315382 | 0.18 |
| 7464 | MAVS/MYO9B ratio | GCST90315390 | 0.18 |
| 7465 | HCLS1 levels | GCST90469437 | 0.18 |
| 7466 | Unstable angina pectoris | FING00001405 | 0.18 |
| 7467 | TBCB/TBCC ratio | GCST90315909 | 0.18 |
| 7468 | Volume of right central nucleus | GCST90474916 | 0.18 |
| 7469 | Methods of admission to hospital (recoded) - Emergency admission: A&E | Summary Administration | UKBB00000464 | 0.18 |
| 7470 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T366 | ECGU000366 | 0.18 |
| 7471 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320897 | 0.18 |
| 7472 | Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers) | FING00000772 | 0.18 |
| 7473 | Total protein levels | GCST90468105 | 0.18 |
| 7474 | CD46/TNFRSF14 ratio | GCST90313838 | 0.18 |
| 7475 | Varicose veins | circulatory system | UKBB00000893 | 0.18 |
| 7476 | CD300LG/DSG2 ratio | GCST90313802 | 0.18 |
| 7477 | PDGFB/PTPN6 ratio | GCST90315625 | 0.18 |
| 7478 | Sjögren's syndrome | GCST90018700 | 0.18 |
| 7479 | Placental weight (fetal genotype, adjusted for sex and gestational age) | GCST90275189 | 0.18 |
| 7480 | MARCO levels | GCST90469861 | 0.18 |
| 7481 | Hip fracture | GCST90161240 | 0.18 |
| 7482 | Urticaria | FING00001408 | 0.18 |
| 7483 | Hip circumference adjusted for BMI | GCST90020028 | 0.17 |
| 7484 | Chronic obstructive pulmonary disease in current smokers | GCST90016593 | 0.17 |
| 7485 | Dupuytren's disease | GCST90301252 | 0.17 |
| 7486 | Chronic diseases of tonsils and adenoids | FING00000283 | 0.17 |
| 7487 | Seen doctor (GP) for nerves, anxiety, tension or depression | Mental health | UKBB00000765 | 0.17 |
| 7488 | IGFBP3 levels | GCST90102624 | 0.17 |
| 7489 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473 | ECGU000473 | 0.17 |
| 7490 | IDP dMRI TBSS MD Splenium of corpus callosum | GCST90004031 | 0.17 |
| 7491 | DTI autoptx L3 ifo l tract | GCST90385205 | 0.17 |
| 7492 | Waist-to-Hip ratio | Body measurement | UKBB00000905 | 0.17 |
| 7493 | Total fatty acid levels | GCST90502727 | 0.17 |
| 7494 | IDP dMRI TBSS MD Superior longitudinal fasciculus R | GCST90004067 | 0.17 |
| 7495 | SORT1 levels | GCST90470710 | 0.17 |
| 7496 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T383 | ECGU000383 | 0.17 |
| 7497 | Hand grip strength (right) | Hand grip strength | UKBB00000301 | 0.17 |
| 7498 | KLRB1/KLRD1 ratio | GCST90315260 | 0.17 |
| 7499 | FAM3B/GPA33 ratio | GCST90314778 | 0.17 |
| 7500 | ISM1 levels | GCST90469630 | 0.17 |
| 7501 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502597 | 0.17 |
| 7502 | MVK/SERPINE1 ratio | GCST90315505 | 0.17 |
| 7503 | Alanine aminotransferase levels | GCST90018723 | 0.17 |
| 7504 | DDAH1 levels | GCST90468966 | 0.17 |
| 7505 | CEACAM1/GGT1 ratio | GCST90314000 | 0.17 |
| 7506 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T286 | ECGU000286 | 0.17 |
| 7507 | Provencibacterium massiliense abundance in stool | GCST90032527 | 0.17 |
| 7508 | Coxarthrosis | FING00000362 | 0.17 |
| 7509 | Neuroticism | GCST002920 | 0.17 |
| 7510 | Malignant neoplasm of kidney, except pelvis (PheCode 189.11) | GCST90475597 | 0.17 |
| 7511 | Loneliness (weighted GWA) | GCST90267289 | 0.16 |
| 7512 | Waist-to-hip ratio adjusted for BMI | GCST90020025 | 0.16 |
| 7513 | F-highly palatable foods liking (derived food-liking factor) | GCST90094785 | 0.16 |
| 7514 | CLEC1B/HBEGF ratio | GCST90314092 | 0.16 |
| 7515 | CCL22/TIMP3 ratio | GCST90313693 | 0.16 |
| 7516 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T382 | ECGU000382 | 0.16 |
| 7517 | SORT1/VSIR ratio | GCST90315870 | 0.16 |
| 7518 | ADAMTSL5 levels | GCST90468230 | 0.16 |
| 7519 | CHGA levels | GCST90240699 | 0.16 |
| 7520 | CD244 levels | GCST90468611 | 0.16 |
| 7521 | F-sweetened coffee drink liking (derived food-liking factor) | GCST90094853 | 0.16 |
| 7522 | ICD10 O24.4: Diabetes mellitus arising in pregnancy | GCST90454236 | 0.16 |
| 7523 | DTI TBSS L3 Splenium of corpus callosum | GCST90384528 | 0.16 |
| 7524 | White blood cell (leukocyte) count | Blood count | UKBB00000913 | 0.16 |
| 7525 | Other intervertebral disk disorders | Other dorsopathies | UKBB00000612 | 0.16 |
| 7526 | Osteoarthritis, localized (PheCode 740.1) | GCST90476254 | 0.16 |
| 7527 | SSC5D levels | GCST90470748 | 0.16 |
| 7528 | IMPACT levels | GCST90469611 | 0.16 |
| 7529 | IDP dMRI ProbtrackX L2 slf l | GCST90004294 | 0.16 |
| 7530 | Glucose | Blood biochemistry | UKBB00000288 | 0.16 |
| 7531 | RND3 levels | GCST90422230 | 0.16 |
| 7532 | Frailty index | GCST90020053 | 0.16 |
| 7533 | ENPP2/TNFRSF11B ratio | GCST90314672 | 0.16 |
| 7534 | IDP T1 FAST ROIs V cerebellum X | GCST90002588 | 0.16 |
| 7535 | CXCL16/NOTCH1 ratio | GCST90314339 | 0.16 |
| 7536 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502396 | 0.16 |
| 7537 | Body mass index | GCST90446645 | 0.16 |
| 7538 | CD244/TREML2 ratio | GCST90313767 | 0.16 |
| 7539 | Behaviour of cancer tumour: malignant, primary site, PHESANT recoding (UKB data field 40012_3) | GCST90043946 | 0.16 |
| 7540 | Spells in hospital | Summary Administration | UKBB00000789 | 0.16 |
| 7541 | INSL4 levels | GCST90469621 | 0.16 |
| 7542 | REST UKBBICA NODEamps25 0014 | GCST90385497 | 0.16 |
| 7543 | Left-hemisphere control network to right-hemisphere control network white-matter structural connectivity | GCST90302750 | 0.16 |
| 7544 | Feeling hurt | GCST006951 | 0.16 |
| 7545 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T288 | ECGA000288 | 0.16 |
| 7546 | Spleen volume | GCST90016667 | 0.16 |
| 7547 | CDSN levels | GCST90468688 | 0.16 |
| 7548 | PLXNB3/SNAP23 ratio | GCST90315693 | 0.16 |
| 7549 | Waist-hip index | GCST90020027 | 0.16 |
| 7550 | FYB1 levels | GCST90469284 | 0.16 |
| 7551 | IDP dMRI ProbtrackX L1 ifo r | GCST90004259 | 0.16 |
| 7552 | Tense / 'highly strung' | Mental health | UKBB00000815 | 0.16 |
| 7553 | SPINT1/SUSD2 ratio | GCST90315878 | 0.16 |
| 7554 | mean platelet volume (MPV, maximum, inv-norm transformed) | GCST90475517 | 0.16 |
| 7555 | IGFBP4 levels | GCST90469530 | 0.16 |
| 7556 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T478 | ECGA000478 | 0.16 |
| 7557 | Prostate cancer | GCST90018685 | 0.16 |
| 7558 | S100A12 levels | GCST90470513 | 0.16 |
| 7559 | Self-rated health | GCST006620 | 0.16 |
| 7560 | IDP T1 FAST ROIs L subcallosal cortex | GCST90002503 | 0.16 |
| 7561 | Principal component-derived dietary pattern 19 | GCST90133024 | 0.16 |
| 7562 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T277 | ECGU000277 | 0.16 |
| 7563 | KLK6/MOG ratio | GCST90315255 | 0.15 |
| 7564 | Methods of admission to hospital (recoded) - Elective admission: Booked | Summary Administration | UKBB00000461 | 0.15 |
| 7565 | TNFRSF6B levels | GCST90470914 | 0.15 |
| 7566 | Bone marrow fat fraction of lumbar vertebra 3 | GCST90652388 | 0.15 |
| 7567 | COL6A3/SMOC2 ratio | GCST90314178 | 0.15 |
| 7568 | MEGF9 levels | GCST90469884 | 0.15 |
| 7569 | Acute renal failure | FING00000030 | 0.15 |
| 7570 | OSMR levels | GCST90470132 | 0.15 |
| 7571 | ITGB1/REG1A ratio | GCST90315228 | 0.15 |
| 7572 | VSIG2 levels | GCST90471051 | 0.15 |
| 7573 | NID1/SORT1 ratio | GCST90315542 | 0.15 |
| 7574 | Volume of left paralaminar nucleus | GCST90474895 | 0.15 |
| 7575 | COPD-related respiratory insufficiency | FING00000352 | 0.15 |
| 7576 | TSPAN1 levels | GCST90470978 | 0.15 |
| 7577 | IDP dMRI TBSS FA Genu of corpus callosum | GCST90003879 | 0.15 |
| 7578 | ATXN10/PRTFDC1 ratio | GCST90313398 | 0.15 |
| 7579 | Gamma glutamyl transferase levels | GCST90278630 | 0.15 |
| 7580 | EPS8L2 levels | GCST90469138 | 0.15 |
| 7581 | Subjective well-being | GCST90104897 | 0.15 |
| 7582 | Oily fish consumption | GCST90132993 | 0.15 |
| 7583 | IDP dMRI ProbtrackX MD slf r | GCST90004241 | 0.15 |
| 7584 | Sensitivity / hurt feelings | Mental health | UKBB00000766 | 0.15 |
| 7585 | Volume of left whole amygdala | GCST90474898 | 0.15 |
| 7586 | LSIL lesion of the cervix uteri, vagina or vulva | FING00000733 | 0.15 |
| 7587 | Urine betaine levels in chronic kidney disease | GCST90264859 | 0.15 |
| 7588 | BST2 levels | GCST90468475 | 0.15 |
| 7589 | CDH1/CDH17 ratio | GCST90313945 | 0.15 |
| 7590 | Diabetes (standard GWA) | GCST90267278 | 0.15 |
| 7591 | Pulse pressure | GCST90018750 | 0.15 |
| 7592 | BA-exvivo rh thickness BA3b | GCST90003530 | 0.15 |
| 7593 | CDHR2/SSC4D ratio | GCST90313965 | 0.15 |
| 7594 | GSTA3/KRT18 ratio | GCST90314997 | 0.15 |
| 7595 | COL1A1/OMD ratio | GCST90314171 | 0.15 |
| 7596 | PRR4 levels | GCST90470338 | 0.15 |
| 7597 | BCR/GOPC ratio | GCST90313491 | 0.15 |
| 7598 | SMPD1/SMPDL3A ratio | GCST90315854 | 0.15 |
| 7599 | MFGE8 levels | GCST90469900 | 0.15 |
| 7600 | HSPG2/IGFBP6 ratio | GCST90315091 | 0.15 |
| 7601 | IDP dMRI TBSS ISOVF Posterior thalamic radiation L | GCST90004506 | 0.15 |
| 7602 | DTI autoptx MD fmi tract | GCST90385231 | 0.15 |
| 7603 | Acetoacetate levels | GCST90092804 | 0.15 |
| 7604 | LAG3 levels | GCST90469727 | 0.15 |
| 7605 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T281 | ECGU000281 | 0.15 |
| 7606 | PLA2G15/PRCP ratio | GCST90315661 | 0.15 |
| 7607 | EBAG9/HBEGF ratio | GCST90314565 | 0.15 |
| 7608 | Functional dyspepsia | FING00000561 | 0.15 |
| 7609 | PPP2R2A levels | GCST90618122 | 0.14 |
| 7610 | DLL1/NBL1 ratio | GCST90314496 | 0.14 |
| 7611 | COMP/DPP4 ratio | GCST90314188 | 0.14 |
| 7612 | Mean bone marrow fat fraction of lumbar vertebrae 1-5 | GCST90652391 | 0.14 |
| 7613 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T499 | ECGU000499 | 0.14 |
| 7614 | DAG1/PDGFB ratio | GCST90314379 | 0.14 |
| 7615 | mean corpuscular volume (MCV, minimum, inv-norm transformed) | GCST90475474 | 0.14 |
| 7616 | IDP dMRI TBSS MD Anterior corona radiata R | GCST90004049 | 0.14 |
| 7617 | Prescriptions - antispasmodic | UKBB00000666 | 0.14 |
| 7618 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T371 | ECGU000371 | 0.14 |
| 7619 | Reason for reducing amount of alcohol drunk - Other reason | Alcohol | UKBB00000735 | 0.14 |
| 7620 | Weight change compared with 1 year ago | General health | UKBB00000911 | 0.14 |
| 7621 | Cognition and processing speed (confirmatory factor analysis Factor 34) | GCST90309368 | 0.14 |
| 7622 | ADGRE5/VCAM1 ratio | GCST90313184 | 0.14 |
| 7623 | Other and unspecified disorders of vitreous body | FING00000934 | 0.14 |
| 7624 | NID2 levels | GCST90470048 | 0.14 |
| 7625 | VWA1 levels | GCST90471061 | 0.14 |
| 7626 | Mean arterial pressure, manual reading | Cardiovascular measurement | UKBB00000442 | 0.14 |
| 7627 | CRTAM/FCRL6 ratio | GCST90314274 | 0.14 |
| 7628 | Lysophosphatidylcholine (24:0) [sn1] levels | GCST90025425 | 0.14 |
| 7629 | Milk type: Skimmed, semi-skimmed or full cream (UKB data field 1418) | GCST90133005 | 0.14 |
| 7630 | BCR/VASH1 ratio | GCST90313499 | 0.14 |
| 7631 | FAM3D levels | GCST90469188 | 0.14 |
| 7632 | A body shape index | GCST90020024 | 0.14 |
| 7633 | CRISP3 levels | GCST90468866 | 0.14 |
| 7634 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T91 | ECGA000091 | 0.14 |
| 7635 | FKBP7 levels | GCST90469245 | 0.14 |
| 7636 | Other cataract | FING00000976 | 0.14 |
| 7637 | Glaucoma (primary open-angle) | GCST90011766 | 0.14 |
| 7638 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T381 | ECGU000381 | 0.14 |
| 7639 | Cancer code, self-reported - basal cell carcinoma | Medical conditions | UKBB00000117 | 0.14 |
| 7640 | ITGB1/ITGB2 ratio | GCST90315225 | 0.14 |
| 7641 | Alcohol abuse, main dg (more control exclusions) | FING00000049 | 0.14 |
| 7642 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T365 | ECGU000365 | 0.14 |
| 7643 | Butyrylcarnitine levels | GCST90243589 | 0.14 |
| 7644 | DCXR levels | GCST90468964 | 0.14 |
| 7645 | GOPC/IRAK4 ratio | GCST90314954 | 0.14 |
| 7646 | Common executive function | GCST90162547 | 0.14 |
| 7647 | Right-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302790 | 0.14 |
| 7648 | mean corpuscular volume (MCV, maximum, inv-norm transformed) | GCST90475466 | 0.14 |
| 7649 | Glucose levels (UKB data field 23470) | GCST90269567 | 0.14 |
| 7650 | SOD2 levels | GCST90470705 | 0.14 |
| 7651 | BDNF levels | GCST90468437 | 0.14 |
| 7652 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T479 | ECGA000479 | 0.14 |
| 7653 | Retinal venular tortuosity | GCST90270399 | 0.14 |
| 7654 | PLXNB2 levels | GCST90470266 | 0.14 |
| 7655 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472 | ECGU000472 | 0.14 |
| 7656 | Urinary albumin excretion | GCST006586 | 0.14 |
| 7657 | FXN/TRIAP1 ratio | GCST90314899 | 0.13 |
| 7658 | TNFSF14 levels | GCST90470922 | 0.13 |
| 7659 | Serine levels | GCST90200415 | 0.13 |
| 7660 | Paternal history of Alzheimer's disease | GCST005920 | 0.13 |
| 7661 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T282 | ECGU000282 | 0.13 |
| 7662 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T289 | ECGU000289 | 0.13 |
| 7663 | Feeling tense | GCST006952 | 0.13 |
| 7664 | WFDC5 levels | GCST90089598 | 0.13 |
| 7665 | Urinary calculus (PheCode 594) | GCST90476143 | 0.13 |
| 7666 | RND3 levels | GCST90618066 | 0.13 |
| 7667 | NEXN levels | GCST90470030 | 0.13 |
| 7668 | TP53I3 levels | GCST90470937 | 0.13 |
| 7669 | IDP dMRI ProbtrackX FA slf l | GCST90003946 | 0.13 |
| 7670 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T226 | ECGA000226 | 0.13 |
| 7671 | PGF levels | GCST90011999 | 0.13 |
| 7672 | White blood cell count | GCST004610 | 0.13 |
| 7673 | aseg lh intensity Accumbens-area | GCST90003774 | 0.13 |
| 7674 | DTI TBSS L2 Sagittal stratum R | GCST90384506 | 0.13 |
| 7675 | Congestive heart failure; nonhypertensive (PheCode 428) | GCST90475981 | 0.13 |
| 7676 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T74 | ECGU000074 | 0.13 |
| 7677 | Depression | GCST003769 | 0.13 |
| 7678 | Colonic or urogenital fistula | FING00000315 | 0.13 |
| 7679 | Types of physical activity in last 4 weeks - Walking for pleasure (not as a means of transport) | Physical activity | UKBB00000875 | 0.13 |
| 7680 | ITGAM/ITGAV ratio | GCST90315209 | 0.13 |
| 7681 | Operative procedures - Unspecified diagnostic endoscopic examination of bladder | Summary Operations | UKBB00000590 | 0.13 |
| 7682 | ERMAP levels | GCST90469147 | 0.13 |
| 7683 | PTPRC levels | GCST90470380 | 0.13 |
| 7684 | Glycine levels | GCST90200707 | 0.13 |
| 7685 | LAG3/VCAM1 ratio | GCST90315270 | 0.13 |
| 7686 | Varicose veins of lower extremities | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | UKBB00000894 | 0.13 |
| 7687 | CASP3/MESD ratio | GCST90313636 | 0.13 |
| 7688 | FGF21 levels | GCST90469222 | 0.13 |
| 7689 | F2R/SEMA4D ratio | GCST90314734 | 0.13 |
| 7690 | CCL13 levels | GCST90468565 | 0.13 |
| 7691 | X-12411 levels | GCST90200492 | 0.13 |
| 7692 | IL12B levels | GCST90274798 | 0.13 |
| 7693 | CAPG levels | GCST90468537 | 0.13 |
| 7694 | Spinal stenosis (PheCode 720) | GCST90476233 | 0.13 |
| 7695 | Bicarbonate (minimum, inv-norm transformed) | GCST90475150 | 0.13 |
| 7696 | Benign neoplasm: Choroid | FING00000170 | 0.13 |
| 7697 | Tea without sugar liking | GCST90094858 | 0.12 |
| 7698 | aparc-DKTatlas rh volume fusiform | GCST90002898 | 0.12 |
| 7699 | Mean bone marrow fat fraction of thoracic vertebrae 8-12 | GCST90652385 | 0.12 |
| 7700 | IDP dMRI ProbtrackX FA ilf l | GCST90003939 | 0.12 |
| 7701 | CCL27 levels | GCST90468579 | 0.12 |
| 7702 | DTI TBSS L2 Superior fronto-occipital fasciculus L | GCST90384519 | 0.12 |
| 7703 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T374 | ECGU000374 | 0.12 |
| 7704 | Citrate levels | GCST90497206 | 0.12 |
| 7705 | Liver enzyme levels (gamma-glutamyl transferase) | GCST90013407 | 0.12 |
| 7706 | Calculus of kidney (PheCode 594.1) | GCST90476145 | 0.12 |
| 7707 | Asthma | respiratory | UKBB00000054 | 0.12 |
| 7708 | PDP1 levels | GCST90424296 | 0.12 |
| 7709 | EIF2AK2 levels | GCST90469091 | 0.12 |
| 7710 | Cellulitis and abscess of leg, except foot (PheCode 681.5) | GCST90476166 | 0.12 |
| 7711 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101) | GCST90320920 | 0.12 |
| 7712 | Loneliness, isolation | Mental health | UKBB00000408 | 0.12 |
| 7713 | Renal failure | FING00001250 | 0.12 |
| 7714 | Abdominal subcutaneous adipose tissue | GCST90267347 | 0.12 |
| 7715 | Visceral adipose tissue | GCST90267357 | 0.12 |
| 7716 | DAG1/HBEGF ratio | GCST90314376 | 0.12 |
| 7717 | Mean volume of bilateral amygdala | GCST90474899 | 0.12 |
| 7718 | Unruptured cerebral aneurysm | GCST90018596 | 0.12 |
| 7719 | PRG3 levels | GCST90470323 | 0.12 |
| 7720 | WARS levels | GCST90471066 | 0.12 |
| 7721 | CCL17/F2R ratio | GCST90313686 | 0.12 |
| 7722 | DKK1/VEGFC ratio | GCST90314484 | 0.12 |
| 7723 | C1QTNF1/COL18A1 ratio | GCST90313551 | 0.12 |
| 7724 | IDP dMRI TBSS L3 Superior corona radiata R | GCST90004195 | 0.12 |
| 7725 | CAG-273 sp003507395 abundance in stool | GCST90032269 | 0.12 |
| 7726 | PSAPL1 levels | GCST90470350 | 0.12 |
| 7727 | Hand grip strength right (UKB data field 47) | GCST90468169 | 0.12 |
| 7728 | FUOM levels | GCST90469276 | 0.12 |
| 7729 | Uterine fibroids | GCST90018714 | 0.12 |
| 7730 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T100 | ECGU000100 | 0.12 |
| 7731 | CDH17/SPINT1 ratio | GCST90313944 | 0.12 |
| 7732 | Lysophosphatidylcholine (22:0) [sn2] levels | GCST90024176 | 0.12 |
| 7733 | AHCY/HSPA1A ratio | GCST90313211 | 0.12 |
| 7734 | Other disorders of intestine | digestive | UKBB00000608 | 0.12 |
| 7735 | EGFL7 levels | GCST90469083 | 0.12 |
| 7736 | HippSubfield rh volume presubiculum-head | GCST90002695 | 0.12 |
| 7737 | Verbal-numerical reasoning | GCST003498 | 0.12 |
| 7738 | GCNT1 levels | GCST90469319 | 0.12 |
| 7739 | aparc-a2009s lh thickness S-cingul-Marginalis | GCST90003648 | 0.12 |
| 7740 | Calculus of ureter (PheCode 594.3) | GCST90476147 | 0.12 |
| 7741 | aseg rh number HolesBeforeFixing | GCST90002647 | 0.12 |
| 7742 | Plasma succinylcarnitine (C4-DC) levels in chronic kidney disease | GCST90265998 | 0.12 |
| 7743 | LILRA2 levels | GCST90469771 | 0.12 |
| 7744 | Number of days/week of moderate physical activity 10+ minutes | Physical activity | UKBB00000533 | 0.12 |
| 7745 | Hallux valgus (acquired) | FING00000601 | 0.12 |
| 7746 | Usual side of head for mobile phone use - Left | Electronic device use | UKBB00000889 | 0.12 |
| 7747 | CDKN1A/TACC3 ratio | GCST90313975 | 0.12 |
| 7748 | Creatinine levels | GCST90025946 | 0.12 |
| 7749 | Asthma | Chronic lower respiratory diseases | UKBB00000053 | 0.12 |
| 7750 | XCL1 levels | GCST90471081 | 0.12 |
| 7751 | Osteoporosis NOS | musculoskeletal | UKBB00000599 | 0.12 |
| 7752 | ASGR2 levels | GCST90468376 | 0.11 |
| 7753 | Hernia | FING00000616 | 0.11 |
| 7754 | IRF2 levels | GCST90241566 | 0.11 |
| 7755 | Fruit intake (weighted GWA) | GCST90267283 | 0.11 |
| 7756 | ITGB6 levels | GCST90469646 | 0.11 |
| 7757 | Premature beats (PheCode 427.6) | GCST90475977 | 0.11 |
| 7758 | FOLR1 levels | GCST90469259 | 0.11 |
| 7759 | TNFSF13 levels | GCST90470921 | 0.11 |
| 7760 | Major dietary changes in the last 5 years - No | Diet | UKBB00000421 | 0.11 |
| 7761 | Frequency of depressed mood in last 2 weeks | Mental health | UKBB00000259 | 0.11 |
| 7762 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T305 | ECGA000305 | 0.11 |
| 7763 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T96 | ECGA000096 | 0.11 |
| 7764 | aparc-Desikan rh volume fusiform | GCST90002807 | 0.11 |
| 7765 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T290 | ECGA000290 | 0.11 |
| 7766 | Osteoporosis | musculoskeletal | UKBB00000598 | 0.11 |
| 7767 | Potassium in urine | Urine assays | UKBB00000655 | 0.11 |
| 7768 | Treatment or medication use - metformin (UKB data field 20003_1140884600) | GCST90042245 | 0.11 |
| 7769 | AGR2 levels | GCST90468253 | 0.11 |
| 7770 | CETN3 levels | GCST90468722 | 0.11 |
| 7771 | Left-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivity | GCST90302699 | 0.11 |
| 7772 | TNFRSF11B levels | GCST90012002 | 0.11 |
| 7773 | Coffee type - Decaffeinated coffee (any type) | Diet | UKBB00000139 | 0.11 |
| 7774 | ANG/RARRES2 ratio | GCST90313271 | 0.11 |
| 7775 | aparc-Desikan rh volume lingual | GCST90002813 | 0.11 |
| 7776 | IDP dMRI TBSS L1 Cingulum hippocampus L | GCST90004112 | 0.11 |
| 7777 | Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney disease | GCST90266045 | 0.11 |
| 7778 | IDP dMRI TBSS MD Posterior limb of internal capsule L | GCST90004046 | 0.11 |
| 7779 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T372 | ECGU000372 | 0.11 |
| 7780 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T290 | ECGU000290 | 0.11 |
| 7781 | Left eye overall retinal pigment epithelium thickness | GCST90672032 | 0.11 |
| 7782 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 71) | GCST90320634 | 0.11 |
| 7783 | GOT1 levels | GCST90469379 | 0.11 |
| 7784 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T230 | ECGU000230 | 0.11 |
| 7785 | CDKN2D/ITGB1BP2 ratio | GCST90313987 | 0.11 |
| 7786 | Coronary artery calcification | GCST90503074 | 0.11 |
| 7787 | F-burn/spicy liking (derived food-liking factor) | GCST90094716 | 0.11 |
| 7788 | GFRA2 levels | GCST90469329 | 0.11 |
| 7789 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T375 | ECGU000375 | 0.11 |
| 7790 | Weekly usage of mobile phone in last 3 months | Electronic device use | UKBB00000908 | 0.11 |
| 7791 | Coffee type: Instant coffee (UKB data field 1508_2) | GCST90041802 | 0.11 |
| 7792 | Goat cheese liking | GCST90094773 | 0.11 |
| 7793 | Phenylacetate levels | GCST90199630 | 0.11 |
| 7794 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65) | GCST90320628 | 0.11 |
| 7795 | FCRL2/TNFRSF13B ratio | GCST90314801 | 0.11 |
| 7796 | Glycated haemoglobin HbA1c levels (UKB data field 30750) | GCST90468072 | 0.11 |
| 7797 | Serum urea levels | GCST90025991 | 0.11 |
| 7798 | Heart failure with reduced EF [Systolic or combined heart failure] (PheCode 428.3) | GCST90475983 | 0.11 |
| 7799 | Lymphoid neoplasms (drug group 1 phenocluster) | GCST90624740 | 0.11 |
| 7800 | PLXNA4/VASH1 ratio | GCST90315691 | 0.11 |
| 7801 | Bioavailable testosterone levels | GCST90012103 | 0.11 |
| 7802 | aseg lh intensity Caudate | GCST90003769 | 0.11 |
| 7803 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T294 | ECGA000294 | 0.10 |
| 7804 | Use of hypnotics and sedatives | FING00001411 | 0.10 |
| 7805 | DLL1/IL18BP ratio | GCST90314495 | 0.10 |
| 7806 | Cardiomyopathy (PheCode 425) | GCST90475949 | 0.10 |
| 7807 | Physical activity (Relative amplitude) | GCST90061432 | 0.10 |
| 7808 | Liver fat | GCST90566817 | 0.10 |
| 7809 | COMP levels | GCST90468827 | 0.10 |
| 7810 | Benign neoplasm of colon | neoplasms | UKBB00000092 | 0.10 |
| 7811 | RAB6A levels | GCST90470412 | 0.10 |
| 7812 | Paradoxical eczema in biologic-treated plaque psoriasis | GCST90162550 | 0.10 |
| 7813 | wg lh intensity-contrast transversetemporal | GCST90003825 | 0.10 |
| 7814 | DLL1 levels | GCST90469004 | 0.10 |
| 7815 | IL15/IL18BP ratio | GCST90315148 | 0.10 |
| 7816 | BST2/CEACAM1 ratio | GCST90313537 | 0.10 |
| 7817 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T376 | ECGU000376 | 0.10 |
| 7818 | IL6 levels | GCST90469604 | 0.10 |
| 7819 | CD27/TNFRSF9 ratio | GCST90313778 | 0.10 |
| 7820 | Peak expiratory flow (PEF) | Spirometry | UKBB00000638 | 0.10 |
| 7821 | Hip index | GCST90020026 | 0.10 |
| 7822 | FABP1/LGALS4 ratio | GCST90314752 | 0.10 |
| 7823 | Monocyte count | GCST90025950 | 0.10 |
| 7824 | IDP dMRI TBSS L1 Superior longitudinal fasciculus R | GCST90004115 | 0.10 |
| 7825 | GP2 levels | GCST90469382 | 0.10 |
| 7826 | aparc-DKTatlas rh volume parstriangularis | GCST90002911 | 0.10 |
| 7827 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T66 | ECGA000066 | 0.10 |
| 7828 | SLITRK2 levels | GCST90470670 | 0.10 |
| 7829 | Ischemic stroke | GCST90018644 | 0.10 |
| 7830 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T225 | ECGA000225 | 0.10 |
| 7831 | Left-hemisphere control network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302748 | 0.10 |
| 7832 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117) | GCST90320680 | 0.10 |
| 7833 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T498 | ECGU000498 | 0.10 |
| 7834 | Torso length to body height ratio | GCST90270262 | 0.10 |
| 7835 | HNRNPK/USP8 ratio | GCST90315070 | 0.10 |
| 7836 | aparc-a2009s rh area G-postcentral | GCST90003398 | 0.10 |
| 7837 | TXNL1 levels | GCST90470993 | 0.10 |
| 7838 | Omega-3 fatty acid levels | GCST90502061 | 0.10 |
| 7839 | REST UKBBICA NODEamps25 0001 | GCST90385484 | 0.10 |
| 7840 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471 | ECGU000471 | 0.10 |
| 7841 | aparc-a2009s rh area S-intrapariet+P-trans | GCST90003426 | 0.10 |
| 7842 | Emotional abuse | GCST90551845 | 0.10 |
| 7843 | Volume of left central nucleus | GCST90474961 | 0.10 |
| 7844 | TRAF3 levels | GCST90470957 | 0.10 |
| 7845 | Trauma exposure | GCST009982 | 0.10 |
| 7846 | aparc-DKTatlas rh volume lingual | GCST90002904 | 0.10 |
| 7847 | Barrett's esophagus (PheCode 530.13) | GCST90476048 | 0.10 |
| 7848 | Age completed full time education | Education | UKBB00000013 | 0.10 |
| 7849 | Sources of admission to hospital (recoded) - Usual Place of residence | Summary Administration | UKBB00000786 | 0.10 |
| 7850 | ThalamNuclei lh volume VPL | GCST90002717 | 0.10 |
| 7851 | CCN2/ENO2 ratio | GCST90313712 | 0.10 |
| 7852 | Longitudinal peak diastolic strain rate | GCST90019013 | 0.10 |
| 7853 | LTA levels | GCST90469813 | 0.10 |
| 7854 | CALCA levels | GCST90468528 | 0.10 |
| 7855 | SRPK2 levels | GCST90470743 | 0.10 |
| 7856 | PCDHB15 levels | GCST90470173 | 0.10 |
| 7857 | Waist circumference adjusted for body mass index | GCST90020029 | 0.10 |
| 7858 | C7 levels | GCST90422332 | 0.10 |
| 7859 | COLEC12/LTBR ratio | GCST90314182 | 0.10 |
| 7860 | IL16 levels | GCST90469557 | 0.10 |
| 7861 | CD300E/EFNA4 ratio | GCST90313797 | 0.09 |
| 7862 | Calculus of kidney and ureter | Urolithiasis | UKBB00000116 | 0.09 |
| 7863 | IDP dMRI TBSS ISOVF Posterior corona radiata L | GCST90004504 | 0.09 |
| 7864 | Volume of left basal nucleus | GCST90474877 | 0.09 |
| 7865 | aparc-a2009s rh volume G-occipital-sup | GCST90003018 | 0.09 |
| 7866 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T485 | ECGU000485 | 0.09 |
| 7867 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T500 | ECGU000500 | 0.09 |
| 7868 | DTI TBSS L2 Uncinate fasciculus R | GCST90384520 | 0.09 |
| 7869 | VSTM1 levels | GCST90471055 | 0.09 |
| 7870 | MPO levels | GCST90012031 | 0.09 |
| 7871 | Prurigo nodularis | FING00001220 | 0.09 |
| 7872 | Phosphatidylcholine acyl-alkyl C36:5 levels | GCST90240073 | 0.09 |
| 7873 | Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levels | GCST90200017 | 0.09 |
| 7874 | Fibroblastic disorders | FING00000542 | 0.09 |
| 7875 | HSDL2 levels | GCST90469485 | 0.09 |
| 7876 | IDP dMRI TBSS FA Retrolenticular part of internal capsule L | GCST90003898 | 0.09 |
| 7877 | CCN3 levels | GCST90468589 | 0.09 |
| 7878 | Bicarbonate (mean, inv-norm transformed) | GCST90475148 | 0.09 |
| 7879 | SPARC levels | GCST90470718 | 0.09 |
| 7880 | Varicose veins of lower extremity | circulatory system | UKBB00000895 | 0.09 |
| 7881 | rfMRI connectivity ICA-features 3 | GCST90006341 | 0.09 |
| 7882 | PPP1R12A/VEGFC ratio | GCST90315715 | 0.09 |
| 7883 | CRADD/STAMBP ratio | GCST90314244 | 0.09 |
| 7884 | Frequency of unenthusiasm / disinterest in last 2 weeks | Mental health | UKBB00000270 | 0.09 |
| 7885 | aparc-Desikan rh volume insula | GCST90002834 | 0.09 |
| 7886 | SPRY2 levels | GCST90470738 | 0.09 |
| 7887 | DKK3 levels | GCST90468998 | 0.09 |
| 7888 | APP/BIN2 ratio | GCST90313316 | 0.09 |
| 7889 | DTI TBSS MD Superior corona radiata R | GCST90384596 | 0.09 |
| 7890 | wg rh intensity-contrast frontalpole | GCST90003858 | 0.09 |
| 7891 | Urine N-acetylglutamate levels in chronic kidney disease | GCST90265569 | 0.09 |
| 7892 | ABHD14B/CRADD ratio | GCST90313141 | 0.09 |
| 7893 | GFAP levels | GCST90469325 | 0.09 |
| 7894 | DAPK2 levels | GCST90468945 | 0.09 |
| 7895 | Glycated hemoglobin levels | GCST90002244 | 0.09 |
| 7896 | RARRES2 levels | GCST90470428 | 0.09 |
| 7897 | DIABLO/GRAP2 ratio | GCST90314466 | 0.09 |
| 7898 | MAP4K5/TBCC ratio | GCST90315385 | 0.09 |
| 7899 | DNER levels | GCST90469019 | 0.09 |
| 7900 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T43 | ECGA000043 | 0.09 |
| 7901 | ARHGAP1/SPARC ratio | GCST90313344 | 0.09 |
| 7902 | TIGIT levels | GCST90470865 | 0.09 |
| 7903 | ITGB7 levels | GCST90469647 | 0.09 |
| 7904 | GM1 ganglioside (d18:1/16:0) levels | GCST90024724 | 0.09 |
| 7905 | Monounsaturated fatty acid levels | GCST90502029 | 0.09 |
| 7906 | Systolic blood pressure (weighted GWA) | GCST90267305 | 0.09 |
| 7907 | SCARB2 levels | GCST90470535 | 0.09 |
| 7908 | CEACAM8 levels | GCST90468698 | 0.09 |
| 7909 | Tea consumption | GCST90096926 | 0.09 |
| 7910 | SFTPA1 levels | GCST90470612 | 0.09 |
| 7911 | DTI TBSS FA Sagittal stratum R | GCST90384410 | 0.09 |
| 7912 | CD69/CLEC1B ratio | GCST90313869 | 0.09 |
| 7913 | aseg rh volume Cerebellum-Cortex | GCST90002636 | 0.09 |
| 7914 | Conjunctivitis | FING00000346 | 0.09 |
| 7915 | HAMP levels | GCST90451683 | 0.09 |
| 7916 | Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61) | GCST90668739 | 0.08 |
| 7917 | CLEC6A levels | GCST90468777 | 0.08 |
| 7918 | Defects in the complement system | FING00000383 | 0.08 |
| 7919 | Depression (broad) | GCST005902 | 0.08 |
| 7920 | Free testosterone levels | GCST90239825 | 0.08 |
| 7921 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T97 | ECGA000097 | 0.08 |
| 7922 | Volume of left accessory basal nucleus | GCST90474874 | 0.08 |
| 7923 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320864 | 0.08 |
| 7924 | S100A11/S100A12 ratio | GCST90315798 | 0.08 |
| 7925 | TIMP3 levels | GCST90470871 | 0.08 |
| 7926 | Reaction time (baseline) | GCST90565838 | 0.08 |
| 7927 | Bifidobacterium kashiwanohense abundance in stool | GCST90032226 | 0.08 |
| 7928 | ZNF830 levels | GCST90471102 | 0.08 |
| 7929 | Principal component-derived dietary pattern 26 | GCST90133031 | 0.08 |
| 7930 | Prescriptions - stimulant laxative|laxative | UKBB00000702 | 0.08 |
| 7931 | Ceramide (d18:2/22:0) levels | GCST90024054 | 0.08 |
| 7932 | CD209 levels | GCST90468608 | 0.08 |
| 7933 | Basal cell carcinoma, excluding all cancers (controls excluding all cancers) | FING00000142 | 0.08 |
| 7934 | aparc-Desikan rh area superiorparietal | GCST90003135 | 0.08 |
| 7935 | GLT25D1 levels | GCST90426421 | 0.08 |
| 7936 | Spleen iron concentration | GCST90101831 | 0.08 |
| 7937 | Omega-3 fatty acids to total fatty acids percentage | GCST90502448 | 0.08 |
| 7938 | Other disorders of cornea | FING00001022 | 0.08 |
| 7939 | Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers) | FING00001067 | 0.08 |
| 7940 | Keratitis | FING00000708 | 0.08 |
| 7941 | Behenoyl dihydrosphingomyelin (d18:0/22:0) levels | GCST90200059 | 0.08 |
| 7942 | Interpolated Age of participant when operation took place | Operations | UKBB00000370 | 0.08 |
| 7943 | Estimated glomerular filtration rate, cystain C | Other measurement | UKBB00000210 | 0.08 |
| 7944 | MDGA1 levels | GCST90469875 | 0.08 |
| 7945 | estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed) | GCST90475285 | 0.08 |
| 7946 | LAT/PDGFA ratio | GCST90315285 | 0.08 |
| 7947 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T288 | ECGU000288 | 0.08 |
| 7948 | Volume of left lateral nucleus | GCST90474889 | 0.08 |
| 7949 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T287 | ECGU000287 | 0.08 |
| 7950 | Operation year/age first occurred | Operations | UKBB00000570 | 0.08 |
| 7951 | ERBB2 levels | GCST90469139 | 0.08 |
| 7952 | Whole body water mass (UKB data field 23102) | GCST90468184 | 0.08 |
| 7953 | Lymphocyte count | GCST90002317 | 0.08 |
| 7954 | rfMRI connectivity (ICA100 edge 1099) | GCST90005952 | 0.08 |
| 7955 | LEP levels | GCST90012076 | 0.08 |
| 7956 | ICA1/YTHDF3 ratio | GCST90315113 | 0.08 |
| 7957 | GZMB levels | GCST90469424 | 0.08 |
| 7958 | Ascending aorta distensibility | GCST90267385 | 0.08 |
| 7959 | T1 FreeSurfer BA rh BA2 exvivo volume | GCST90385576 | 0.08 |
| 7960 | GP6/HPCAL1 ratio | GCST90314963 | 0.08 |
| 7961 | TNF levels | GCST90470924 | 0.08 |
| 7962 | MESD/NCK2 ratio | GCST90315421 | 0.08 |
| 7963 | DPY30 levels | GCST90469037 | 0.08 |
| 7964 | ANGPTL4 levels | GCST90468305 | 0.08 |
| 7965 | Malignant neoplasm of female breast (PheCode 174.11) | GCST90041833 | 0.08 |
| 7966 | Basal metabolic rate (UKB data field 23105) | GCST90468159 | 0.08 |
| 7967 | aparc-DKTatlas lh volume cuneus | GCST90002865 | 0.08 |
| 7968 | mean corpuscular volume (MCV, mean, inv-norm transformed) | GCST90475470 | 0.08 |
| 7969 | Impedance of whole body (UKB data field 23106) | GCST90468173 | 0.08 |
| 7970 | Pancreas volume | GCST90016669 | 0.08 |
| 7971 | DOK2/PDLIM7 ratio | GCST90314535 | 0.08 |
| 7972 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477 | ECGU000477 | 0.08 |
| 7973 | DTI TBSS L2 Retrolenticular part of internal capsule L | GCST90384497 | 0.08 |
| 7974 | Phosphate levels | GCST90200393 | 0.08 |
| 7975 | Scoliosis | FING00001281 | 0.08 |
| 7976 | CXCL11/SDC4 ratio | GCST90314336 | 0.08 |
| 7977 | IDP dMRI ProbtrackX MD atr r | GCST90004222 | 0.07 |
| 7978 | Disorders of plasma-protein metabolism, not elsewhere classified | FING00000455 | 0.07 |
| 7979 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T101 | ECGU000101 | 0.07 |
| 7980 | DTI TBSS MD Posterior corona radiata R | GCST90384598 | 0.07 |
| 7981 | aparc-DKTatlas rh area superiorparietal | GCST90003292 | 0.07 |
| 7982 | Treatment/medication code - ventolin 100micrograms inhaler | Medications | UKBB00000860 | 0.07 |
| 7983 | ADA2 levels | GCST90468215 | 0.07 |
| 7984 | Obesity | Obesity and other hyperalimentation | UKBB00000545 | 0.07 |
| 7985 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T289 | ECGA000289 | 0.07 |
| 7986 | Cardiac pacemaker in situ (PheCode 426.91) | GCST90475960 | 0.07 |
| 7987 | ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrhea | GCST90454219 | 0.07 |
| 7988 | Extrapyramidal and movement disorders | FING00000527 | 0.07 |
| 7989 | HSIL lesion of the vulva | FING00000626 | 0.07 |
| 7990 | Plasma 3-hydroxybutyroylglycine** levels in chronic kidney disease | GCST90264488 | 0.07 |
| 7991 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T373 | ECGU000373 | 0.07 |
| 7992 | TXNDC15 levels | GCST90470990 | 0.07 |
| 7993 | FOXO1/SNAP23 ratio | GCST90314875 | 0.07 |
| 7994 | Left-hemisphere default mode network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302761 | 0.07 |
| 7995 | Gastritis and duodenitis | digestive | UKBB00000277 | 0.07 |
| 7996 | Obesity | endocrine/metabolic | UKBB00000544 | 0.07 |
| 7997 | X-12216 levels | GCST90200483 | 0.07 |
| 7998 | Lysophosphatidylcholine (24:0) [sn2] levels | GCST90025426 | 0.07 |
| 7999 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470 | ECGU000470 | 0.07 |
| 8000 | Myocardial infarction (PheCode 411.2) | GCST90043954 | 0.07 |